Rezeda Shamagsumova

Dr. Rezeda Shamagsumova

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2020 in Chemosensors
Verified
Journal Article
Open access
PDF file
GEGennady Evtugyn
Gennady Evtugyn
APAnna Porfireva
Anna Porfireva
RSRezeda Shamagsumova
Rezeda Shamagsumova
Tibor HianikTibor Hianik
Tibor Hianik
Carbon nanomaterials offer unique opportunities for the assembling of electrochemical aptasensors due to their high electroconductivity, redox activity, compatibility with biochemical receptors and broad possibilities of functionalization and combination with other auxiliary reagents. In this review, the progress in the development of electrochemical aptasensors based on carbon nanomaterials in 2016–2020 is considered with particular emphasis on the role of carbon materials in aptamer immobilization and signal generation. The synthesis and properties of carbon nanotubes, graphene materials, carbon nitride, carbon black particles and fullerene are described and their implementation in the electrochemical biosensors are summarized. Examples of electrochemical aptasensors are classified in accordance with the content of the surface layer and signal measurement mode. In conclusion, the drawbacks and future prospects of carbon nanomaterials’ application in electrochemical aptasensors are briefly discussed.

9 February 2024 in Biosensors
Verified
Journal Article
Open access
PDF file
Alexey IvanovAlexey Ivanov
Alexey Ivanov
RSRezeda Shamagsumova
Rezeda Shamagsumova
MLMarina Larina
Marina Larina
GEGennady Evtugyn
Gennady Evtugyn
Neurodegenerative diseases and Alzheimer’s disease (AD), as one of the most common causes of dementia, result in progressive losses of cholinergic neurons and a reduction in the presynaptic markers of the cholinergic system. These consequences can be compensated by the inhibition of acetylcholinesterase (AChE) followed by a decrease in the rate of acetylcholine hydrolysis. For this reason, anticholinesterase drugs with reversible inhibition effects are applied for the administration of neurodegenerative diseases. Their overdosage, variation in efficiency and recommendation of an individual daily dose require simple and reliable measurement devices capable of the assessment of the drug concentration in biological fluids and medications. In this review, the performance of electrochemical biosensors utilizing immobilized cholinesterases is considered to show their advantages and drawbacks in the determination of anticholinesterase drugs. In addition, common drugs applied in treating neurodegenerative diseases are briefly characterized. The immobilization of enzymes, nature of the signal recorded and its dependence on the transducer modification are considered and the analytical characteristics of appropriate biosensors are summarized for donepezil, huperzine A, rivastigmine, eserine and galantamine as common anti-dementia drugs. Finally, the prospects for the application of AChE-based biosensors in clinical practice are discussed.

14 June 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
AGAnastasia Goida
Anastasia Goida
TKTatiana Kulikova
Tatiana Kulikova
RSRezeda Shamagsumova
Rezeda Shamagsumova
VEVladimir Evtugyn
Vladimir Evtugyn
ASAnatoly Saveliev
Anatoly Saveliev
APAnna Porfireva
Anna Porfireva
A novel nanocomposite based on electrochemically reduced graphene oxide (ERGO) and electropolymerized polyproflavine (PPFL) was obtained within a “one-pot” synthesis from natural deep eutectic solvent (NADES). NADES consisted of citric acid, glucose, and water in a molar ratio of 1:1:6. The synthesis was carried out in potentiostatic mode by consequent potential application in cathodic and anodic areas. The composite was applied to develop the impedimetric DNA sensor for anthracycline determination. The sensor has provided linear range from 10 nM to 0.1 mM for doxorubicin, from 1 pM to 10 nM for epirubicin, and from 10 pM to 10 nM for idarubicin, with the limit of detection 3 nM, 1 pM, and 5 pM, respectively. The concentrations of doxorubicin below 10 nM did not have any other influence on epirubicin and idarubicin determination despite their molecular structure similarity. The sensor developed was used for the determination of anticancer medications, such as doxorubicin, epirubicin, and idarubicin, in their standard solutions, pharmaceuticals, artificial, and human urine samples. It is worth noting that the additions of mannitol and lactose, which are the stabilizers of the pharmaceuticals, exhibited an interfering effect on the sensor response.

15 May 2023 in Sensors
Verified
Journal Article
Open access
PDF file
TKTatiana Kulikova
Tatiana Kulikova
RSRezeda Shamagsumova
Rezeda Shamagsumova
ARAlexey Rogov
Alexey Rogov
Ivan StoikovIvan Stoikov
Ivan Stoikov
Pavel PadnyaPavel Padnya
Pavel Padnya
GEGennady Evtugyn
Gennady Evtugyn
The assembling of thiacalix[4]arene-based dendrimers in cone, partial cone, and 1,3-alternate configuration on the surface of a glassy carbon electrode coated with carbon black or multiwalled carbon nanotubes has been characterized using cyclic voltammetry, electrochemical impedance spectroscopy, and scanning electron microscopy. Native and damaged DNA were electrostatically accumulated on the modifier layer. The influence of the charge of the redox indicator and of the macrocycle/DNA ratio was quantified and the roles of the electrostatic interactions and of the diffusional transfer of the redox indicator to the electrode interface indicator access were established. The developed DNA sensors were tested on discrimination of native, thermally denatured, and chemically damaged DNA and on the determination of doxorubicin as the model intercalator. The limit of detection of doxorubicin established for the biosensor based on multi-walled carbon nanotubes was equal to 1.0 pM with recovery from spiked human serum of 105–120%. After further optimization of the assembling directed towards the stabilization of the signal, the developed DNA sensors can find application in the preliminary screening of antitumor drugs and thermal damage of DNA. They can also be applied for testing potential drug/DNA nanocontainers as future delivery systems.


27 November 2024 in Journal of Solid State Electrochemistry
Verified
Journal Article
Closed access
PDF file
RSRezeda Shamagsumova
Rezeda Shamagsumova
KGKarina Gayazova
Karina Gayazova
Dmitriy ShurpikDmitriy Shurpik
Dmitriy Shurpik
VEVladimir Evtugyn
Vladimir Evtugyn
DSDaniil Stoikov
Daniil Stoikov
GEGennady Evtugyn
Gennady Evtugyn